We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$21.8B
AUM Growth
+$3.36B
(+18%)
Cap. Flow
+$2.78B
Cap. Flow
% of AUM
12.74%
Top 10 Holdings %
Top 10 Hldgs %
12.04%
Holding
3,109
New
1,280
Increased
559
Reduced
519
Closed
699
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$363M |
| 2 |
Tencent Music
TME
|
+$184M |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$182M |
| 4 |
Baidu
BIDU
|
+$146M |
| 5 |
Gaotu Techedu
GOTU
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$204M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$189M |
| 3 |
Zoetis
ZTS
|
+$182M |
| 4 |
Guardant Health
GH
|
+$136M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.03% |
| 2 | Consumer Discretionary | 13.15% |
| 3 | Technology | 10.68% |
| 4 | Financials | 9.81% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Ball Corp
BALL
$17B
| $18M | 0.08% |
+212,688
| New | +$18.6M |
|
|
CONX
252
DELISTED
CONX Corp. Class A Common Stock
CONX
| $17.9M | 0.08% |
+1,799,972
| New | +$18.6M |
|
253
Vale
VALE
$62.9B
| $17.7M | 0.08% |
1,016,496
+202,285
| +25% | +$3.53M |
|
254
Advanced Drainage Systems
WMS
$10.9B
| $17.6M | 0.08% |
+169,843
| New | +$16.6M |
|
255
Sonos
SONO
$1.75B
| $17.4M | 0.08% |
464,149
+329,926
| +246% | +$11.1M |
|
256
Deere & Co
DE
$170B
| $17.3M | 0.08% |
46,291
-204,708
| -82% | -$67.2M |
|
257
Tapestry
TPR
$28.8B
| $17.3M | 0.08% |
419,004
-397,467
| -49% | -$15.3M |
|
258
GDS Holdings
GDS
$6.34B
| $17M | 0.08% |
210,180
+196,767
| +1,467% | +$19.6M |
|
259
Star Bulk Carriers
SBLK
$3.14B
| $17M | 0.08% |
+1,158,874
| New | +$15M |
|
260
Mettler-Toledo International
MTD
$26.8B
| $16.9M | 0.08% |
+14,660
| New | +$17M |
|
|
ALBO
261
DELISTED
Albireo Pharma Inc
ALBO
| $16.9M | 0.08% |
480,067
-187,636
| -28% | -$6.93M |
|
262
Hamilton Lane
HLNE
$3.63B
| $16.9M | 0.08% |
191,071
+53,558
| +39% | +$4.52M |
|
|
FSNB.U
263
DELISTED
Fusion Acquisition Corp. II Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
FSNB.U
| $16.9M | 0.08% |
+1,698,301
| New | +$16.9M |
|
264
PUT
VanEck Gold Miners ETF
GDX
$23B
| $16.7M | 0.08% |
+513,700
| New | +$17.5M |
|
265
Progressive
PGR
$124B
| $16.6M | 0.08% |
173,799
+164,159
| +1,703% | +$14.9M |
|
|
XYZ
266
Block Inc
XYZ
$45.9B
| $16.4M | 0.08% |
72,267
-119,570
| -62% | -$28M |
|
267
Bank of America
BAC
$435B
| $16.4M | 0.08% |
423,243
+165,519
| +64% | +$5.71M |
|
268
Omega Healthcare
OHI
$15.4B
| $16.3M | 0.07% |
445,235
+415,073
| +1,376% | +$15.3M |
|
269
Tyler Technologies
TYL
$12.2B
| $16.2M | 0.07% |
38,247
+37,438
| +4,628% | +$16.2M |
|
270
SPDR Gold Trust
GLD
$131B
| $16.1M | 0.07% |
100,825
-16,311
| -14% | -$2.74M |
|
|
TWCT
271
DELISTED
TWC Tech Holdings II Corp. Class A Common Stock
TWCT
| $16M | 0.07% |
1,623,271
+123,286
| +8% | +$1.29M |
|
272
Fortive
FTV
$19B
| $15.9M | 0.07% |
297,904
-220,681
| -43% | -$11.4M |
|
|
COHR
273
DELISTED
Coherent Inc
COHR
| $15.8M | 0.07% |
62,599
+60,890
| +3,563% | +$13.5M |
|
274
Roblox
RBLX
$34B
| $15.8M | 0.07% |
+244,134
| New | +$17M |
|
275
Boston Scientific
BSX
$65.8B
| $15.8M | 0.07% |
409,374
-325,708
| -44% | -$12.3M |
|
Similar funds
Marshall Wace's Q1 2021 Portfolio in Review
As of Q1 2021, Marshall Wace held 3,109 positions worth $21.8B, up 18% from $18.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace deployed $2.78B of net new capital in Q1 2021, opening 1,280 new positions and adding to 559 existing holdings. Its largest new stake was Paramount Global Class B: 5,936,494 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $204M trimmed.
- Marshall Wace's largest Q1 2021 buy was Paramount Global Class B: 5,936,494 shares worth $268M.
- Marshall Wace added most to Farfetch Limited Class A Ordinary Shares in Q1 2021, an estimated $182M increase.
- Marshall Wace's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $204M.
- Marshall Wace fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q1 2021, selling an estimated $76.2M.
- Marshall Wace's ten largest holdings make up 12% of its $21.8B portfolio in Q1 2021.
- Marshall Wace opened 1,280 new positions and closed 699 in Q1 2021.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $21.8B.
Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.